BioLargo, Inc.
BLGO
$0.22
$0.01537.47%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.15M | -2.40M | -2.12M | -2.78M | -3.67M |
| Total Depreciation and Amortization | 280.00K | 236.00K | 257.00K | 265.00K | 291.00K |
| Total Amortization of Deferred Charges | 28.00K | -- | 0.00 | 0.00 | 0.00 |
| Total Other Non-Cash Items | 155.00K | 479.00K | 1.19M | 1.88M | 1.79M |
| Change in Net Operating Assets | -2.83M | -1.52M | -620.00K | 130.00K | -258.00K |
| Cash from Operations | -5.52M | -3.21M | -1.29M | -508.00K | -1.84M |
| Capital Expenditure | -372.00K | -1.24M | -1.41M | -1.57M | -1.29M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -82.00K | -82.00K | -- | -- | -- |
| Cash from Investing | -454.00K | -1.32M | -1.41M | -1.57M | -1.29M |
| Total Debt Issued | 1.45M | 864.00K | 65.00K | 65.00K | 65.00K |
| Total Debt Repaid | -13.00K | -14.00K | 43.00K | 35.00K | 33.00K |
| Issuance of Common Stock | 2.07M | 2.86M | 3.46M | 2.93M | 2.75M |
| Repurchase of Common Stock | -1.28M | -1.28M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.99M | 2.01M | 35.00K | 323.00K | 1.39M |
| Cash from Financing | 4.22M | 4.44M | 3.61M | 3.35M | 4.23M |
| Foreign Exchange rate Adjustments | -22.00K | 94.00K | -69.00K | -80.00K | -26.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.77M | 9.00K | 840.00K | 1.19M | 1.07M |